Skip to content
LuckTech Media

Zimbabwe Rejects ‘One-Sided’ American Health Aid Deal Due to Data Concerns

Health funding image
The proposed US funding was intended for initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has turned down a substantial US healthcare agreement worth 367 million US dollars (£272m) over five years because of the United States' request for confidential information.

This rejection came to light after a official document dated December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the agreement was "lopsided".

An official spokesperson later explained that the US was requesting biological samples for research and commercial purposes while refused to guarantee the resulting advantages from any future treatments.

"We are forced to start the challenging and unfortunate process of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the United States had donated more than $1.9bn in health funding to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has called for further negotiations to secure a deal suitable to all parties so the nation's critical HIV programme can continue.

Broader Background

Zimbabwe's decision follows a similar situation in Kenya, where a high court blocked a related deal with the US following concerns were filed about the safety of citizens' health data.

After returning to the presidency last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.

USAID had managed aid for the US government, but Trump argued its expenditure was "inefficient" and his administration was pursuing government-to-government deals to boost transparency and responsibility.

Based on statements, 16 nations in Africa have to date agreed to these new health pacts, representing over $18.3bn in committed funds.

Details of the Declined Agreement

This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We believe this partnership would have delivered immense advantages for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment through American-funded initiatives," Tremont commented.

However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".

"Our nation was requested to provide its genetic material and health information indefinitely, without any equivalent promise of access to any scientific breakthroughs – like new medicines or tests – that could be developed from that shared data," Mangwana explained.

"Put simply, our nation would provide the raw materials for medical research with no assurance that the final treatments would be accessible to our population should a new pandemic arise."

National Interest and Global Health

Mangwana further pointed out that the American exit from the global health body and its push of one-on-one health agreements were upending structures previously established through the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to deal with potential global health emergencies.

"This mechanism is designed to ensure that when a country provides its samples, the benefits – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to develop them."

These objections over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.

"We encourage continued dialogue with our American counterparts on how future collaboration might be arranged in a way that honours the sovereignty and dignity of each country."

Medical Community Response

Medical experts expressed it understood the official position, but recommended that talks should continue given that a large portion of the nation's Aids initiatives relied on external financing.

"If technical issues arise, such as those involving information security or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," the group added.

This impasse underscores the complex debate between accepting vital international aid and protecting a country's data in an increasingly data-driven world.

About the author

Sara Cooper

A tech journalist with over a decade of experience covering UK innovation and digital transformation for leading publications.

LuckTech Media

Type to search articles.